Why Israel is becoming a hub for Parkinson s research | US & World News jewishaz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishaz.com Daily Mail and Mail on Sunday newspapers.
New Therapy To Treat Advanced Form Of Parkinsons Disease by Pooja Shete on January 22, 2021 at 8:17 PM
The study conducted at Ben-Gurion University of the Negev is published in the clinical neurology journal
Brain.
Parkinson s disease affects over one million people in U.S. and 10 million worldwide. Parkinson s disease causes symptoms like tremors and severe movement impairment due to progressive degeneration of dopaminergic neurons.
The protein present in all human brains called alpha-synuclein misfolds and forms toxic clumps in the cells found to be the main cause of the Parkinson s disease. Current therapies for Parkinson s improve symptoms but they are not effective in the advanced stage of illness and they do not slow or cure the disease.
E-Mail
BEER-SHEVA, Israel.January 20, 2021 -Ben-Gurion University of the Negev researchers have discovered that the protein BMP5/7 offers promising therapeutics that could slow down or halt the progression of Parkinson s disease.
The findings were published in the prestigious clinical neurology journal,
Parkinson s disease, which affects over one million people in U.S. and 10 million worldwide, causes tremors and severe movement impairment due to progressive degeneration of dopamine-producing brain cells. It is believed that the protein alpha-synuclein, present in all human brains, misfolds and forms toxic clumps in these cells, which causes the disease.
While current Parkinson s disease therapies improve symptoms, they are not effective in advanced illness stages and, unfortunately, do not slow or cure the disease.
Ben-Gurion University of the Negev researchers have discovered that the protein BMP5/7 offers promising therapeutics that could slow down or halt the progression of Parkinson's disease.